Compass Ion Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.71M Buy
14,597
+26
+0.2% +$6.06K 0.32% 39
2026
Q1
$3.56M Buy
14,571
+36
+0.2% +$8.38K 0.34% 37
2025
Q4
$3.01M Buy
14,535
+172
+1% +$34K 0.29% 45
2025
Q3
$2.66M Sell
14,363
-282
-2% -$48.3K 0.26% 50
2025
Q2
$2.24M Buy
14,645
+89
+0.6% +$13.7K 0.24% 51
2025
Q1
$2.41M Buy
14,556
+830
+6% +$130K 0.28% 44
2024
Q4
$1.99M Sell
13,726
-807
-6% -$125K 0.24% 55
2024
Q3
$2.36M Sell
14,533
-352
-2% -$56.1K 0.29% 47
2024
Q2
$2.35M Hold
14,885
0.34% 40
2024
Q1
$2.35M Sell
14,885
-93
-0.6% -$14.8K 0.34% 41
2023
Q4
$2.35M Buy
14,978
+135
+0.9% +$20.7K 0.36% 39
2023
Q3
$2.31M Buy
14,843
+9,057
+157% +$1.49M 0.4% 36
2023
Q2
$958K Buy
5,786
+15
+0.3% +$2.42K 0.24% 36
2023
Q1
$895K Buy
5,771
+240
+4% +$38.8K 0.23% 35
2022
Q4
$977K Sell
5,531
-25
-0.4% -$4.32K 0.25% 34
2022
Q3
$908K Buy
5,556
+39
+0.7% +$6.6K 0.25% 30
2022
Q2
$979K Hold
5,517
0.28% 30
2022
Q1
$978K Buy
5,517
+33
+0.6% +$5.62K 0.3% 33
2021
Q4
$938K Sell
5,484
-169
-3% -$27.7K 0.3% 38
2021
Q3
$913K Sell
5,653
-3,936
-41% -$672K 0.33% 36
2021
Q2
$1.58M Buy
9,589
+2,101
+28% +$348K 0.61% 19
2021
Q1
$1.23M Buy
7,488
+187
+3% +$30.3K 0.51% 23
2020
Q4
$1.15M Buy
7,301
+41
+0.6% +$6.05K 0.44% 22
2020
Q3
$1.08M Buy
7,260
+1,555
+27% +$230K 0.69% 17
2020
Q2
$802K Hold
5,705
0.72% 19
2020
Q1
$748K Buy
5,705
+84
+1% +$11.9K 0.67% 19
2019
Q4
$820K Buy
+5,621
New +$762K 0.42% 19

Other funds holding JNJ

Compass Ion Advisors's JNJ Position: Q2 2026 in Review

Compass Ion Advisors increased its Johnson & Johnson (JNJ) stake by 0.18% in Q2 2026, buying an estimated $6.06K and bringing the position to 14,597 shares worth $3.71M. The position accounts for 0.32% of the portfolio, ranked #39.

Compass Ion Advisors first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Compass Ion Advisors held 14,597 shares of Johnson & Johnson worth $3.71M as of Q2 2026.
  • Compass Ion Advisors bought 26 Johnson & Johnson shares in Q2 2026, an estimated $6.06K.
  • Johnson & Johnson made up 0.32% of Compass Ion Advisors's portfolio in Q2 2026, its #39 holding.
  • Compass Ion Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.